Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-05-21

FDA Approved: DONEPEZIL HYDROCHLORIDE — Supplemental Application (Alembic Pharmaceuticals Inc.)

View source ↗

Summary

The FDA approved a supplemental ANDA for donepezil hydrochloride, permitting a generic version of the Alzheimer's disease therapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Donepezil hydrochloride (Donepezil hydrochloride)

Snippet

SUPPL AP for DONEPEZIL HYDROCHLORIDE (DONEPEZIL HYDROCHLORIDE)